Convolutional Neural Networks (CNN)s have become a prominent method of AI 26 implementation in medical classification tasks. Grading Diabetic Retinopathy (DR) has been 27 at the forefront of the development of AI for ophthalmology. However, major obstacles remain 28 in the generalization of these CNN's onto real-world DR screening programs. We believe these 29 difficulties are due to use of 1) small training datasets (<5,000 images), 2) private and 'curated' 30 repositories, 3) offline CNN implementation methods, while 4) relying on accuracy measured 31 as area under the curve (AUC) as the sole measure of CNN performance. 32 To address these issues, the public EyePACS Kaggle Diabetic Retinopathy dataset was 33 uploaded onto Microsoft Azure™ cloud platform. Two CNNs were trained as a "Quality 34 Assurance", and a "Classifier". The "Classifier" CNN performance was then tested both on 35 'un-curated' as well as the 'curated' test set created by the "Quality Assessment" CNN. Finally, 36 the sensitivity of the "Classifier" CNNs was boosted post-training using two post-training 37 techniques.
Inception-ResNet-V2 (39). The "Quality-Assessment" CNN was then based on a modified 139 version of the InceptionResNet-V2 architecture. For our purposes, the number of neurons in the final output layer was changed to two, corresponding to 'adequate' and 'inadequate' 141 classes. The learning rate was 0.001, using ADAM optimizer, with a mini-batch size of 30, and 142 training was continued to 100 epochs. The Gaussian blur technique has been designed to remove the variation between images due to 172 differing lighting conditions, camera resolution and image qualities [ Figure 3 ]. To our knowledge, the 'margin max' technique has not previously applied in similar studies.
209
In this method, if the top two less sever classes' probabilities (e.g. Healthy and Non-referable The cross-entropy and accuracy were tracked and recorded throughout the training and 235 validation process. The training progress was monitored for 100 epochs and the best set of weights that resulted in minimal validation loss was picked and set for the proceeding CNN 237 performance assessment.
238
While, the "Classifier" CNN was trained and validated using 'un-curated' data, it was tested 239 separately using unseen 'curated' and 'un-curated' data. One would assume that using 'curated' 240 (i.e. higher quality) data for the CNN test would improve the performance of the model. Here 241 and for the first time, we wanted to assess this hypothesis [ Table 3&4 ].
242 all the excitement none of this work has progressed to a clinically useful tool, providing a real-299 world AI-solution for DR screening programs. This is due largely to the inability of the 300 research-driven AI to generalize to a real-world setup. Whilst there are many reasons for such 301 a lack of generalisation, the principal ones are the use of small and 'curated' datasets and an 302 emphasis on overall accuracy, rather than sensitivity of the developed AI. The AI's reliance on 303 powerful computers that are not available in most clinical environments has been an additional 304 contributory factor.
305
During this research, we endeavoured to address those issues that hinder the clinical translation 306 of an in-house developed AI for DR screening. Our "Classifier" CNN was developed and tested 307 using real-world 'un-curated' data. Here we demonstrated that our "Classifier" CNN is 308 'robust', as its performance is not critically affected by the quality of the input data.
309
Furthermore, this process of data management, model training and validation was performed 310 using Microsoft's Azure™ cloud platform. In doing so, we have demonstrated that one can 311 build AI that is constantly re-trainable and scalable through cloud computing platforms.
312
Although few DR AIs are accessible online, to our knowledge this is the first time that an AI 313 is fully implemented and re-trainable through a cloud platform. Hence, provided there is 314 internet access, our AI is capable of reaching remote and rural places; areas traditionally not 315 well served by existing DR screening services. 316 We have also successfully experimented with two "sensitivity-boosting" techniques,
317
'cascading thresholds' and the 'margin max' technique. We observed good improvements in 318 sensitivities and specificities of either Healthy or Diseased grades, depending on the application 319 mode. In doing so we boosted the AI's sensitivity to detect Healthy cases to more than 98%, (while also improving the specificities of the other more severe classes). These techniques also 321 boosted the AI's sensitivity of referable disease classes to near 80%.
322
The sensitivity of a screening test is the percentage of the condition that is correctly detected; 323 the specificity of a screening test is the percentage of people that one refers unnecessarily.
324
Within all screening programs, the need to balance high sensitivity with an acceptable 325 specificity has been long recognised. for adjudication and quality assurance.
362
Arguably, one of the biggest challenges that faces all AI-based "diagnostic" systems is the 363 issue of public trust. Whereas it is accepted that in a screening program with a sensitivity of 364 90%, 1 in 10 patients will be informed that are healthy when in actual fact they have diseases, 365 well-publicised failures of AI systems suggest that the public would not accept such failure 366 rates from a "computer" (61). Whilst the relatively simple CNN described in this paper lacks 367 the required sensitivity to be the sole arbitrator for identifying referable disease in a structured 368 screening program, the fact that the methods we describe boosted the sensitivity of the CNN to 369 detect disease by over 10% in most cases is noteworthy. We therefore believe that the techniques we describe here will prove to be valuable tools for those looking to build bespoke 371 CNN's in the future.
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In conclusion, we have demonstrated how existing machine learning techniques can be used to 373 boost the sensitivity of a CNN classifier to detect both health and disease. We have also 
